At a Glance

Designing ieso’s First AI Therapy Product

Turning an ambitious clinical proposition into a coherent native mobile experience.

I led product design from early concept through clinically evaluated iOS and Android apps — aligning therapy science, real-world needs and business goals to create Velora’s first complete product experience.

Role

Head of Design → Design Director

Focus

Product vision, experience design, service design

Worked with

Clinical, AI, Engineering, Product, Data Science

When

2022–2026

At a Glance

Designing ieso’s First AI Therapy Product

Turning an ambitious clinical proposition into a coherent native mobile experience.

I led product design from early concept through clinically evaluated iOS and Android apps — aligning therapy science, real-world needs and business goals to create Velora’s first complete product experience.

Role

Head of Design → Design Director

Focus

Product vision, experience design, service design

Worked with

Clinical, AI, Engineering, Product, Data Science

When

2022–2026

At a Glance

Designing ieso’s First AI Therapy Product

Turning an ambitious clinical proposition into a coherent native mobile experience.

I led product design from early concept through clinically evaluated iOS and Android apps — aligning therapy science, real-world needs and business goals to create Velora’s first complete product experience.

Role

Head of Design → Design Director

Focus

Product vision, experience design, service design

Worked with

Clinical, AI, Engineering, Product, Data Science

When

2022–2026

At a Glance

Designing ieso’s First AI Therapy Product

Turning an ambitious clinical proposition into a coherent native mobile experience.

I led product design from early concept through clinically evaluated iOS and Android apps — aligning therapy science, real-world needs and business goals to create Velora’s first complete product experience.

Role

Head of Design → Design Director

Focus

Product vision, experience design, service design

Worked with

Clinical, AI, Engineering, Product, Data Science

When

2022–2026

At a Glance

Designing ieso’s First AI Therapy Product

Turning an ambitious clinical proposition into a coherent native mobile experience.

I led product design from early concept through clinically evaluated iOS and Android apps — aligning therapy science, real-world needs and business goals to create Velora’s first complete product experience.

Role

Head of Design → Design Director

Focus

Product vision, experience design, service design

Worked with

Clinical, AI, Engineering, Product, Data Science

When

2022–2026

The Challenge

Make evidence-based therapy accessible, personal and effective at scale.

For People

Manage anxiety and build lasting skills.

For Healthcare providers

Offer a trustworthy, easy-to-integrate digital therapy.

For ieso

Deliver clinically evaluated outcomes with measurable impact.

My Contribution

Defined the product vision and experience strategy for Velora’s first native mobile product.

Designed the end-to-end experience across therapy, insights and support.

Partnered with clinical and engineering teams to build, test and launch.

The Impact

Clinically Meaningful Improvement

In a pre-release US study, more than half of participants achieved clinically meaningful improvements after around 90 minutes of use.

Strong User Response

Around 89% of participants in the UK study reported being satisfied.

Improvements in the Range Reported for Face-to-Face Therapy

The US study reported effect sizes in the range seen in face-to-face therapy.

Commercial Traction

Velora supported new partnerships and continued investment in the product.

The Challenge

Make evidence-based therapy accessible, personal and effective at scale.

For People

Manage anxiety and build lasting skills.

For Healthcare providers

Offer a trustworthy, easy-to-integrate digital therapy.

For ieso

Deliver clinically evaluated outcomes with measurable impact.

My Contribution

Defined the product vision and experience strategy for Velora’s first native mobile product.

Designed the end-to-end experience across therapy, insights and support.

Partnered with clinical and engineering teams to build, test and launch.

The Impact

Clinically Meaningful Improvement

In a pre-release US study, more than half of participants achieved clinically meaningful improvements after around 90 minutes of use.

Strong User Response

Around 89% of participants in the UK study reported being satisfied.

Improvements in the Range Reported for Face-to-Face Therapy

The US study reported effect sizes in the range seen in face-to-face therapy.

Commercial Traction

Velora supported new partnerships and continued investment in the product.

The Challenge

Make evidence-based therapy accessible, personal and effective at scale.

For People

Manage anxiety and build lasting skills.

For Healthcare providers

Offer a trustworthy, easy-to-integrate digital therapy.

For ieso

Deliver clinically evaluated outcomes with measurable impact.

My Contribution

Defined the product vision and experience strategy for Velora’s first native mobile product.

Designed the end-to-end experience across therapy, insights and support.

Partnered with clinical and engineering teams to build, test and launch.

The Impact

Clinically Meaningful Improvement

In a pre-release US study, more than half of participants achieved clinically meaningful improvements after around 90 minutes of use.

Strong User Response

Around 89% of participants in the UK study reported being satisfied.

Improvements in the Range Reported for Face-to-Face Therapy

The US study reported effect sizes in the range seen in face-to-face therapy.

Commercial Traction

Velora supported new partnerships and continued investment in the product.

The Challenge

Make evidence-based therapy accessible, personal and effective at scale.

For People

Manage anxiety and build lasting skills.

For Healthcare providers

Offer a trustworthy, easy-to-integrate digital therapy.

For ieso

Deliver clinically evaluated outcomes with measurable impact.

My Contribution

Defined the product vision and experience strategy for Velora’s first native mobile product.

Designed the end-to-end experience across therapy, insights and support.

Partnered with clinical and engineering teams to build, test and launch.

The Impact

Clinically Meaningful Improvement

In a pre-release US study, more than half of participants achieved clinically meaningful improvements after around 90 minutes of use.

Strong User Response

Around 89% of participants in the UK study reported being satisfied.

Improvements in the Range Reported for Face-to-Face Therapy

The US study reported effect sizes in the range seen in face-to-face therapy.

Commercial Traction

Velora supported new partnerships and continued investment in the product.

The Challenge

Make evidence-based therapy accessible, personal and effective at scale.

For People

Manage anxiety and build lasting skills.

For Healthcare providers

Offer a trustworthy, easy-to-integrate digital therapy.

For ieso

Deliver clinically evaluated outcomes with measurable impact.

My Contribution

Defined the product vision and experience strategy for Velora’s first native mobile product.

Designed the end-to-end experience across therapy, insights and support.

Partnered with clinical and engineering teams to build, test and launch.

The Impact

Clinically Meaningful Improvement

In a pre-release US study, more than half of participants achieved clinically meaningful improvements after around 90 minutes of use.

Strong User Response

Around 89% of participants in the UK study reported being satisfied.

Improvements in the Range Reported for Face-to-Face Therapy

The US study reported effect sizes in the range seen in face-to-face therapy.

Commercial Traction

Velora supported new partnerships and continued investment in the product.

From Clinical Vision to a Cohesive Product

A design journey to turn evidence-based therapy into a clear, engaging native mobile experience.

1

Defining the Product Direction

Translated clinical, user and business needs into a shared product vision and an experience teams could build towards.

2

Grounding the Experience in Real Lives

Used research and testing to understand how therapy needed to fit around people’s routines, expectations and emotional needs.

3

Designing the Therapy Journey

Turned clinical content into structured sessions, exercises, progress feedback and support that felt coherent as one experience.

4

Evaluating the Experience

Used usability research, live product data and clinical studies to refine the product and assess usability, satisfaction and early clinical outcomes.

“Love love love this intervention. You gave me my life back. Really needed this. Thank you.”

Research participant • NAVIGATE study

That’s the Short Version

Continue for a closer look at how research, programme structure and small product decisions shaped ieso’s first AI therapy product.

From Clinical Vision to a Cohesive Product

A design journey to turn evidence-based therapy into a clear, engaging native mobile experience.

1

Defining the Product Direction

Translated clinical, user and business needs into a shared product vision and an experience teams could build towards.

2

Grounding the Experience in Real Lives

Used research and testing to understand how therapy needed to fit around people’s routines, expectations and emotional needs.

3

Designing the Therapy Journey

Turned clinical content into structured sessions, exercises, progress feedback and support that felt coherent as one experience.

4

Evaluating the Experience

Used usability research, live product data and clinical studies to refine the product and assess usability, satisfaction and early clinical outcomes.

“Love love love this intervention. You gave me my life back. Really needed this. Thank you.”

Research participant • NAVIGATE study

That’s the Short Version

Continue for a closer look at how research, programme structure and small product decisions shaped ieso’s first AI therapy product.

From Clinical Vision to a Cohesive Product

A design journey to turn evidence-based therapy into a clear, engaging native mobile experience.

1

Defining the Product Direction

Translated clinical, user and business needs into a shared product vision and an experience teams could build towards.

2

Grounding the Experience in Real Lives

Used research and testing to understand how therapy needed to fit around people’s routines, expectations and emotional needs.

3

Designing the Therapy Journey

Turned clinical content into structured sessions, exercises, progress feedback and support that felt coherent as one experience.

4

Evaluating the Experience

Used usability research, live product data and clinical studies to refine the product and assess usability, satisfaction and early clinical outcomes.

“Love love love this intervention. You gave me my life back. Really needed this. Thank you.”

Research participant • NAVIGATE study

That’s the Short Version

Continue for a closer look at how research, programme structure and small product decisions shaped ieso’s first AI therapy product.

From Clinical Vision to a Cohesive Product

A design journey to turn evidence-based therapy into a clear, engaging native mobile experience.

1

Defining the Product Direction

Translated clinical, user and business needs into a shared product vision and an experience teams could build towards.

2

Grounding the Experience in Real Lives

Used research and testing to understand how therapy needed to fit around people’s routines, expectations and emotional needs.

3

Designing the Therapy Journey

Turned clinical content into structured sessions, exercises, progress feedback and support that felt coherent as one experience.

4

Evaluating the Experience

Used usability research, live product data and clinical studies to refine the product and assess usability, satisfaction and early clinical outcomes.

“Love love love this intervention. You gave me my life back. Really needed this. Thank you.”

Research participant • NAVIGATE study

That’s the Short Version

Continue for a closer look at how research, programme structure and small product decisions shaped ieso’s first AI therapy product.

From Clinical Vision to a Cohesive Product

A design journey to turn evidence-based therapy into a clear, engaging native mobile experience.

1

Defining the Product Direction

Translated clinical, user and business needs into a shared product vision and an experience teams could build towards.

2

Grounding the Experience in Real Lives

Used research and testing to understand how therapy needed to fit around people’s routines, expectations and emotional needs.

3

Designing the Therapy Journey

Turned clinical content into structured sessions, exercises, progress feedback and support that felt coherent as one experience.

4

Evaluating the Experience

Used usability research, live product data and clinical studies to refine the product and assess usability, satisfaction and early clinical outcomes.

“Love love love this intervention. You gave me my life back. Really needed this. Thank you.”

Research participant • NAVIGATE study

That’s the Short Version

Continue for a closer look at how research, programme structure and small product decisions shaped ieso’s first AI therapy product.

Closer Look · About 5 min · 5 chapters

01

Setting the Direction

Before there were screens, we needed to understand who Velora was for, what it needed to help with and why people would choose it.

01

Setting the Direction

Before there were screens, we needed to understand who Velora was for, what it needed to help with and why people would choose it.

Understanding Who Velora Needed to Work For

Velora began with a question: could evidence-based therapy be delivered effectively by AI? Answering it took more than an interface. The product had to keep the therapy effective, feel credible and engaging to the people using it, and be worth paying for.

Working with Research, I drew on findings from 62 moderated interviews across the UK and US. They helped define who the product was for, how it could fit in their lives and how the experience needed to feel. Those findings shaped the tone of voice, session pacing, visuals and content, and the segments we designed for.

Segments and design principles defined from lived-experience research.

Segments and design principles defined from lived-experience research

Where the Market Fell Short

A competitive audit found plenty of mental health apps offering tools and content, but very few offering structured, outcome-driven guidance. We chose to build a clinically grounded programme with a clear path through it, rather than another library of exercises.

Designing for the Buyer as Well as the Patient

With Business Development, I mapped the clinical, technical, financial and product roles involved in a provider’s decision, then built messaging for each stage. It kept the buyer’s questions visible while we designed and later helped shape how Velora was offered to partners.

A competitor audit revealed the gap that set the direction: guidance towards an outcome, not another library of tools

02

Finding the Right Shape for the Programme

How much therapy can you ask of someone before they stop turning up?

02

Finding the Right Shape for the Programme

How much therapy can you ask of someone before they stop turning up?

First Model

Therapy, Translated

The first programme mirrored conventional therapy closely: six weeks, a fixed schedule, longer sessions. Clinically it was complete, and parts of it tested well. End to end, engagement fell away.

Programme v1 — a fixed six-week structure with longer scheduled sessions.

Programme v1 — a fixed six-week structure with longer scheduled sessions

Second Model

Shorter, Flexible, Continual

We rebuilt the programme around ten-minute sessions paired with practical exercises, and a recommended cadence people could follow at their own pace. Generative AI made the conversation more responsive. This was the programme taken into the formal studies described in Chapter 05.

Programme v2 — shorter sessions, a clearer cadence and practical exercises between them.

Programme v2 — shorter sessions, a clearer cadence and practical exercises between them

Second Model

Shorter, Flexible, Continual

We rebuilt the programme around ten-minute sessions paired with practical exercises, and a recommended cadence people could follow at their own pace. Generative AI made the conversation more responsive. This was the programme taken into the formal studies described in Chapter 05.

Programme v2 — shorter sessions, a clearer cadence and practical exercises between them.

Programme v2 — shorter sessions, a clearer cadence and practical exercises between them

It feels like therapy and working through my issues is less of a ‘once a week, for an hour’ thing and more of a continual activity and conversation.

Study participant, diary study

It feels like therapy and working through my issues is less of a ‘once a week, for an hour’ thing and more of a continual activity and conversation.

Study participant, diary study

One Programme, Several Delivery Models

As provider conversations progressed, we blueprinted hybrid variants — where clinical and non-clinical human support could sit alongside the AI — so the same programme could flex to different customers without being redesigned each time.

Service blueprint — where human support enters the programme.

Service blueprint — where human support enters the programme

03

Turning the Programme into a Product

The programme had a shape. The interface needed to make it feel intuitive.

03

Turning the Programme into a Product

The programme had a shape. The interface needed to make it feel intuitive.

Working with Clinical and Engineering, I defined the purpose, user goals and required elements for each screen before moving into detailed design. That kept the structure grounded in what people needed, rather than becoming a collection of features. The app settled around three main parts:

Today

What should I do now?

My Journey

How far have I come?

Therapy Room

Where do sessions happen?

Together, they made a fairly involved care programme easier to understand without exposing all its complexity at once. I also explored several visual directions before settling on one that felt warm, calm and human — clinically credible, without feeling clinical.

Three parts, each answering a different question: what should I do now, how far have I come, and where do sessions happen?

The overall vibe and feeling of the program here feels very… light, it feels airy. It feels designed to be approachable, friendly.

Study participant, diary study

The overall vibe and feeling of the program here feels very… light, it feels airy. It feels designed to be approachable, friendly.

Study participant, diary study

04

Sharpening the Details

Once the structure was clear, research showed where smaller points of friction were stopping people from starting, returning and engaging.

04

Sharpening the Details

Once the structure was clear, research showed where smaller points of friction were stopping people from starting, returning and engaging.

Research and product data showed where people still stalled: before their first session, between sessions, when they were asked to give a fuller response, and when it was time to practise. Those moments became the focus for the next round of iteration.

Insight

People Left Before They Started

New users faced sixteen clinical questionnaires before their first session. The data showed many dropped out before reaching it.

Design Response

I broke onboarding into smaller steps, explained why each question was being asked, let people preview what their programme would cover, and led them straight into session one.

Evidence

Product analytics showed a higher proportion of people going on to start the care programme after the change.

It was very quick and simple. Very straightforward.

Study participant, usability testing

The revised onboarding flow — shorter steps, clearer explanations and a direct route into session one.

The revised onboarding flow — shorter steps, clearer explanations and a direct route into session one

Insight

People Left Before They Started

New users faced sixteen clinical questionnaires before their first session. The data showed many dropped out before reaching it.

Design Response

I broke onboarding into smaller steps, explained why each question was being asked, let people preview what their programme would cover, and led them straight into session one.

Evidence

Product analytics showed a higher proportion of people going on to start the care programme after the change.

It was very quick and simple. Very straightforward.

Study participant, usability testing

The revised onboarding flow — shorter steps, clearer explanations and a direct route into session one.

The revised onboarding flow — shorter steps, clearer explanations and a direct route into session one

Insight

People Simply Forgot to Come Back

Diary studies kept surfacing the same thing. The first release had one generic push notification, which was not enough to bring anyone back.

Design Response

Five core notification types across the programme, tailored to the person’s condition and to the specific session or practice they were on, each carrying a clear reason to return. I defined the flows and framework, and wrote and tested the copy for every session.

Evidence

“Telling me how much time I need to spend on the next session is very helpful.” — Study participant

The ‘no pressure’ tone is appealing.

Lived experience member

A notification framework tailored to the person’s condition and place in the programme.

A notification framework tailored to the person’s condition and place in the programme

Insight

People Simply Forgot to Come Back

Diary studies kept surfacing the same thing. The first release had one generic push notification, which was not enough to bring anyone back.

Design Response

Five core notification types across the programme, tailored to the person’s condition and to the specific session or practice they were on, each carrying a clear reason to return. I defined the flows and framework, and wrote and tested the copy for every session.

Evidence

“Telling me how much time I need to spend on the next session is very helpful.” — Study participant

The ‘no pressure’ tone is appealing.

Lived experience member

A notification framework tailored to the person’s condition and place in the programme.

A notification framework tailored to the person’s condition and place in the programme

The smallest change with the biggest result

Letting People Talk Instead of Type

The therapy agent worked better when people gave longer, more detailed answers. That is hard work on a phone. A full audio experience was out of scope, so I redesigned the text input to make the phone’s own speech-to-text one tap away. Live product data from a customer deployment showed how readily people took it up.

42%

of users used speech-to-text

28%

of users used it more than typing

Input detail — message composer with the mic affordance visible

Ending Each Session with a Clear Next Step

Ending a session was another chance to support the programme’s rhythm. Foundations sessions encouraged people to carry straight on while momentum was high. Practice sessions did the opposite: they suggested taking a day or two to try the exercise, with a reminder ready for the next session.

Different endings for different jobs: keep going through Foundations, or pause long enough to practise.

Different endings for different jobs: keep going through Foundations, or pause long enough to practise.

05

Evidence and What Came Next

What the studies showed — and where the product went next.

05

Evidence and What Came Next

What the studies showed — and where the product went next.

Usability and experience

Usable, Supportive and Worthwhile

A UK pragmatic study of 299 participants evaluated the anxiety programme. It scored 78.6 on the System Usability Scale, and around 89% of participants reported being satisfied. The interviews added context: people valued the structured but flexible experience, the sense of being guided while still in control, and the availability of human support. The clearest opportunity was deeper personalisation.

78.6

System Usability Scale

~89%

reported being satisfied

~300

UK participants

It was like having a cheerleader on your side.

Study participant, post-intervention

It was like having a cheerleader on your side.

Study participant, post-intervention

Safety and effectiveness

Early Evidence of Safety and Effectiveness

A US single-arm proof-of-concept study analysed outcomes for 81 adults. After around 90 minutes of use, more than half achieved clinically meaningful improvements in anxiety and depression, with effect sizes above 1.0. More than 80% reported feeling safe, supported and guided. No harmful outputs were observed in live use, and deterioration rates remained within expected bounds for psychotherapy.

~90 min

of interaction

>50%

achieved clinically meaningful improvement

80%+

felt safe, supported and guided

What came next

From Native Apps to the Web

The clinically evaluated iOS and Android apps established the core experience and gave ieso evidence that the approach was worth taking forward. Customers increasingly wanted a white-labelled product they could deploy or integrate into their own services, while ieso needed something easier to maintain across devices. The responsive web product carried the strongest patterns forward and supported a broader API-first offer.

What came next

From Native Apps to the Web

The clinically evaluated iOS and Android apps established the core experience. Customers increasingly wanted a white-labelled product they could deploy or integrate into their own services, while ieso needed something easier to maintain across devices. The responsive web product carried the strongest patterns forward and supported a broader API-first offer.

What came next

From Native Apps to the Web

The clinically evaluated iOS and Android apps established the core experience. Customers increasingly wanted a white-labelled product they could deploy or integrate into their own services, while ieso needed something easier to maintain across devices. The responsive web product carried the strongest patterns forward and supported a broader API-first offer.

Carrying the core experience into a white-labelled responsive web app

Reflection

Velora brought together two parts of design I particularly enjoy: helping shape what a product should become, then staying close to the decisions that make it work. The wider challenge was to turn an ambitious model of AI-led therapy into something clinically credible, buildable and clear enough for people and providers to trust.

It became real through much smaller decisions: how long a session should be, what a notification says at nine on a Tuesday evening, and how easily someone can speak instead of type. Much of my role was moving between those levels, keeping the bigger direction connected to what people actually encountered.

Reflection

Velora brought together two parts of design I particularly enjoy: helping shape what a product should become, then staying close to the decisions that make it work. The wider challenge was to turn an ambitious model of AI-led therapy into something clinically credible, buildable and clear enough for people and providers to trust.


It became real through much smaller decisions: how long a session should be, what a notification says at nine on a Tuesday evening, and how easily someone can speak instead of type. Much of my role was moving between those levels, keeping the bigger direction connected to what people actually encountered.

Reflection

Velora brought together two parts of design I particularly enjoy: helping shape what a product should become, then staying close to the decisions that make it work. The wider challenge was to turn an ambitious model of AI-led therapy into something clinically credible, buildable and clear enough for people and providers to trust.

It became real through much smaller decisions: how long a session should be, what a notification says at nine on a Tuesday evening, and how easily someone can speak instead of type. Much of my role was moving between those levels, keeping the bigger direction connected to what people actually encountered.

Reflection

Velora brought together two parts of design I particularly enjoy: helping shape what a product should become, then staying close to the decisions that make it work. The wider challenge was to turn an ambitious model of AI-led therapy into something clinically credible, buildable and clear enough for people and providers to trust.


It became real through much smaller decisions: how long a session should be, what a notification says at nine on a Tuesday evening, and how easily someone can speak instead of type. Much of my role was moving between those levels, keeping the bigger direction connected to what people actually encountered.

© 2026 - Jack Larner